Transforming immunotherapy with Tempus

See how A2 Biotherapeutics is enhancing its clinical development progress for a cell therapy using HLA LOH as a biomarker and Tempus' comprehensive immunotherapy platform.

Jun 01, 2021
Life Sciences
Webinar
Dr. Denise LauSenior Director of Computational Immunology, Tempus
Dr. William GoM.D., SVP
Head of Development

Related content

Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Smooth vertical gradient transitioning from dark blue to light blue and white.

2026 ASCO® Annual Meeting

2026-04-13
Providers
Life Sciences
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Tempus-Events_Gradient-pill2x

ISPOR 2026

2026-04-09
Life Sciences
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Tempus_5

ACRP 2026 Annual Conference

2026-04-01
Providers
Life Sciences